EXPRESSIONS OF TLR4 AND MYD88, AND THEIR CORRELATION WITH CLINICO-PATHOLOGICAL FEATURES IN PATIENTS WITH COLORECTAL CANCER

被引:0
|
作者
Liang Cancan [1 ]
Wang Haikun [2 ]
Ke Yue [1 ]
Ji Wenjing [1 ]
机构
[1] Xinjiang Med Univ, Dept Digest Internal Med, Affiliated Hosp 2, Xinjiang 830000, Peoples R China
[2] Xinjiang Med Univ, Dept Digest Internal Med, Affiliated Hosp 1, Xinjiang 830000, Peoples R China
来源
ACTA MEDICA MEDITERRANEA | 2018年 / 34卷 / 06期
关键词
TLR4; MyD88; Colorectal cancer; Clinico-pathological features; Prognosis; ACTIVATION;
D O I
10.19193/0393-6384_2018_6_272
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To investigate the expressions of TLR4 and MyD88, and their correlations with clinicopathological features in patients with colorectal cancer. Methods: A total of 234 patients were selected for this study and divided into two groups of 117 patients each, namely: study group (patients with colorectal cancer over a period of two years) and control (patients with normal intestinal mucosal tissues). They consisted of 68 males and 49 females aged between 29 and 67 years (mean age = 52 years). Patients in the study group were staged using TNM staging criteria for colorectal cancer Immunohistochemistry was used to determine the degree of expressions of Toll-like receptor 4 (71R4) and myeloid differentiation factor (MyD88) in colorectal cancer and normal mucosal tissues. The relationship between the expressions of TLR4 and MyD88, and clinical characteristics and prognosis was also assessed.. Results: The expressions of TLR4 and MyD88 in colorectal cancer tissues were significantly higher (p < 0.05), when compared to control, and were positively correlated with TIVM staging, liver metastasis and vascular invasion. Patients with low expressions of T1124 and MyD88 had significantly longer (p < 0.05) survival time than those with high expressions, and the expressions of TLR4 and MyD88, and TNM staging had significant impact (p < 0.05) on the prognosis of colorectal cancer. Conclusion: There is a positive correlation between the expressions of TLR4 and MyD88, and clinic-pathological features such as TAM staging, metastasis, and vascular invasion of patients with colorectal cancer.
引用
收藏
页码:1931 / 1936
页数:6
相关论文
共 50 条
  • [1] Expression of TLR4/MyD88 signaling pathway proteins and correlation with clinical and pathological features of colorectal cancer patients
    Li, Hongyun
    Zhao, Quanjing
    Liu, Jie
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (05): : 6388 - 6396
  • [2] TLR4 and MyD88 and Mismatch Repair Genes in Colorectal Cancer
    Scarpa, Marco
    Ruffolo, Cesare
    Scarpa, Melania
    Canal, Fabio
    Kotsafti, Andromachi
    Erroi, Francesca
    Basato, Silvia
    Fiorot, Alain
    Pozza, Anna
    Brun, Paola
    Tos, Angelo P. Dei
    Castagliuolo, Ignazio
    Castoro, Carlo
    GASTROENTEROLOGY, 2016, 150 (04) : S962 - S963
  • [3] Correlation of TLR4/MyD88 signaling with early miscarriage
    Song, Fang
    Yang, Meixia
    Chen, Jing
    Zhao, Ziwei
    He, Shuai
    Wang, Lihong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (03): : 3601 - 3608
  • [4] MyD88 and TLR4 Expression in Epithelial Ovarian Cancer
    Block, Matthew S.
    Vierkant, Robert A.
    Rambau, Peter F.
    Winham, Stacey J.
    Wagner, Philipp
    Traficante, Nadia
    Toloczko, Aleksandra
    Tiezzi, Daniel G.
    Taran, Florin Andrei
    Sinn, Peter
    Sieh, Weiva
    Sharma, Raghwa
    Rothstein, Joseph H.
    Ramon y Cajal, Teresa
    Paz-Ares, Luis
    Oszurek, Oleg
    Orsulic, Sandra
    Ness, Roberta B.
    Nelson, Gregg
    Modugno, Francesmary
    Menkiszak, Janusz
    McGuire, Valerie
    McCauley, Bryan M.
    Mack, Marie
    Lubinski, Jan
    Longacre, Teri A.
    Li, Zheng
    Lester, Jenny
    Kennedy, Catherine J.
    Kalli, Kimberly R.
    Jung, Audrey Y.
    Johnatty, Sharon E.
    Jimenez-Linan, Mercedes
    Jensen, Allan
    Intermaggio, Maria P.
    Hung, Jillian
    Herpel, Esther
    Hernandez, Brenda Y.
    Hartkopf, Andreas D.
    Harnett, Paul R.
    Ghatage, Prafull
    Garcia-Bueno, Jose M.
    Gao, Bo
    Fereday, Sian
    Eilber, Ursula
    Edwards, Robert P.
    de Sousa, Christiani B.
    de Andrade, Jurandyr M.
    Chudecka-Glaz, Anita
    Chenevix-Trench, Georgia
    MAYO CLINIC PROCEEDINGS, 2018, 93 (03) : 307 - 320
  • [5] Significance of TLR4/MyD88 expression in breast cancer
    Chen, Xiangjin
    Zhao, Feng
    Zhang, Huihao
    Zhu, Youzhi
    Wu, Kunlin
    Tan, Guozheng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (06): : 7034 - 7039
  • [6] TLR4 and MyD88 Expression in Cancer Stem Cells
    Cooke, A. A.
    Gallagher, M. F.
    O'Toole, S. A.
    Martin, C. M.
    Sheils, O. M.
    O'Leary, J. J.
    MODERN PATHOLOGY, 2011, 24 : 441A - 441A
  • [7] TLR4 and MyD88 Expression in Cancer Stem Cells.
    Cooke, A. A.
    Gallagher, M. F.
    O'Toole, S. A.
    Martin, C. M.
    Sheils, O. M.
    O'Leary, J. J.
    LABORATORY INVESTIGATION, 2011, 91 : 441A - 441A
  • [8] Study on the correlation of the TLR4/MyD88 axis with the degree of inflammatory response in patients with synovitis of the knee joint
    Yang, Yanyan
    Lu, Xia
    Sun, Xiaoli
    Li, Min
    Mierzhati, Ayinigeer
    Li, Huazhang
    CELLULAR AND MOLECULAR BIOLOGY, 2023, 69 (07) : 191 - 195
  • [9] Soyasaponins reduce inflammation by downregulating MyD88 expression and suppressing the recruitments of TLR4 and MyD88 into lipid rafts
    Chen, Junbin
    Ullah, Hidayat
    Zheng, Zhongdaixi
    Gu, Xiangfu
    Su, Chuhong
    Xiao, Lingyu
    Wu, Xinglong
    Xiong, Fei
    Li, Qing
    Zha, Longying
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2020, 20 (01)
  • [10] TLR4/MyD88 signaling determines the metastatic potential of breast cancer cells
    Wu, Kunlin
    Zhang, Huihao
    Fu, Yajuan
    Zhu, Youzhi
    Kong, Lingjun
    Chen, Ling
    Zhao, Feng
    Yu, Liangfei
    Chen, Xiangjin
    MOLECULAR MEDICINE REPORTS, 2018, 18 (03) : 3411 - 3420